Zymeworks Inc. Common StockZYME
± ผสมเงินทุนความเกี่ยวข้อง
Zymeworks reports earnings but will not host a call due to the Theravance acquisition; no financial results or deal updates are provided.
ผลกระทบต่อสินทรัพย์ 2
Biotech & Genomic Medicine
Zymeworks Inc. Common Stock
Theravance Biopharma IncTBPH
± ผสมเงินทุนความเกี่ยวข้อง
Theravance Biopharma is the acquisition target; the news is about Zymeworks' earnings schedule and the acquisition, but no new details on the deal's impact.